Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis.

Vinogradova SV, Zhudenkov KV, Benson N, Van Der Graaf PH, Demin OV, Karelina TA.

J Theor Biol. 2015 Oct 7;382:91-8. doi: 10.1016/j.jtbi.2015.06.041. Epub 2015 Jul 8.

PMID:
26163367
2.

Comparison of asymptotic confidence sets for regression in small samples.

Kolobkov D, Demin O, Metelkin E.

J Biopharm Stat. 2016;26(4):742-57. doi: 10.1080/10543406.2015.1052818. Epub 2015 Jun 22.

PMID:
26099035
3.

Analysis of the efficacy of SGLT2 inhibitors using semi-mechanistic model.

Demin O Jr, Yakovleva T, Kolobkov D, Demin O.

Front Pharmacol. 2014 Oct 13;5:218. doi: 10.3389/fphar.2014.00218. eCollection 2014.

4.

Systems pharmacology of the nerve growth factor pathway: use of a systems biology model for the identification of key drug targets using sensitivity analysis and the integration of physiology and pharmacology.

Benson N, Matsuura T, Smirnov S, Demin O, Jones HM, Dua P, van der Graaf PH.

Interface Focus. 2013 Apr 6;3(2):20120071. doi: 10.1098/rsfs.2012.0071.

5.

Modeling of celiac disease immune response and the therapeutic effect of potential drugs.

Demin OO, Smirnov SV, Sokolov VV, Cucurull-Sanchez L, Pichardo-Almarza C, Flores MV, Benson N, Demin OV.

BMC Syst Biol. 2013 Jul 5;7:56. doi: 10.1186/1752-0509-7-56.

6.

Regulation of leukotriene and 5oxoETE synthesis and the effect of 5-lipoxygenase inhibitors: a mathematical modeling approach.

Karelina TA, Zhudenkov KV, Demin OO, Svetlichny DV, Agoram B, Fairman D, Demin OV.

BMC Syst Biol. 2012 Nov 12;6:141. doi: 10.1186/1752-0509-6-141.

7.

Kinetic modelling of central carbon metabolism in Escherichia coli.

Peskov K, Mogilevskaya E, Demin O.

FEBS J. 2012 Sep;279(18):3374-85. doi: 10.1111/j.1742-4658.2012.08719.x.

8.

Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.

Agoram BM, Demin O.

Drug Discov Today. 2011 Dec;16(23-24):1031-6. doi: 10.1016/j.drudis.2011.10.001. Epub 2011 Oct 13. Review.

PMID:
22020181
9.

DBSolve Optimum: a software package for kinetic modeling which allows dynamic visualization of simulation results.

Gizzatkulov NM, Goryanin II, Metelkin EA, Mogilevskaya EA, Peskov KV, Demin OV.

BMC Syst Biol. 2010 Aug 10;4:109. doi: 10.1186/1752-0509-4-109.

10.

In Silico Screening of Nonsteroidal Anti-Inflammatory Drugs and Their Combined Action on Prostaglandin H Synthase-1.

Goltsov A, Lebedeva G, Humphery-Smith I, Goltsov G, Demin O, Goryanin I.

Pharmaceuticals (Basel). 2010 Jul 2;3(7):2059-2081.

11.

Modeling of ATP-ADP steady-state exchange rate mediated by the adenine nucleotide translocase in isolated mitochondria.

Metelkin E, Demin O, Kovács Z, Chinopoulos C.

FEBS J. 2009 Dec;276(23):6942-55. doi: 10.1111/j.1742-4658.2009.07394.x. Epub 2009 Oct 26.

12.

Kinetic modeling as a tool to integrate multilevel dynamic experimental data.

Mogilevskaya E, Bagrova N, Plyusnina T, Gizzatkulov N, Metelkin E, Goryacheva E, Smirnov S, Kosinsky Y, Dorodnov A, Peskov K, Karelina T, Goryanin I, Demin O.

Methods Mol Biol. 2009;563:197-218. doi: 10.1007/978-1-60761-175-2_11.

PMID:
19597787
13.

Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations.

Goltsov A, Maryashkin A, Swat M, Kosinsky Y, Humphery-Smith I, Demin O, Goryanin I, Lebedeva G.

Eur J Pharm Sci. 2009 Jan 31;36(1):122-36. doi: 10.1016/j.ejps.2008.10.015. Epub 2008 Nov 5.

PMID:
19028575
14.

Kinetic modeling of ace operon genetic regulation in Escherichia coli.

Peskov K, Goryanin I, Prank K, Tobin F, Demin O.

J Bioinform Comput Biol. 2008 Oct;6(5):933-59.

PMID:
18942160
15.

Kinetic model of phosphofructokinase-1 from Escherichia coli.

Peskov K, Goryanin I, Demin O.

J Bioinform Comput Biol. 2008 Aug;6(4):843-67.

PMID:
18763746
16.

The Edinburgh human metabolic network reconstruction and its functional analysis.

Ma H, Sorokin A, Mazein A, Selkov A, Selkov E, Demin O, Goryanin I.

Mol Syst Biol. 2007;3:135. Epub 2007 Sep 18.

17.

Kinetic model of mitochondrial Krebs cycle: unraveling the mechanism of salicylate hepatotoxic effects.

Mogilevskaya E, Demin O, Goryanin I.

J Biol Phys. 2006 Oct;32(3-4):245-71. doi: 10.1007/s10867-006-9015-y. Epub 2006 Oct 26.

18.

Cellular kinetic modeling of the microbial metabolism.

Goryanin II, Lebedeva GV, Mogilevskaya EA, Metelkin EA, Demin OV.

Methods Biochem Anal. 2006;49:437-88. Review. No abstract available.

PMID:
16929691
19.

The kinetic model of the shikimate pathway as a tool to optimize enzyme assays for high-throughput screening.

Noble M, Sinha Y, Kolupaev A, Demin O, Earnshaw D, Tobin F, West J, Martin JD, Qiu C, Liu WS, DeWolf WE Jr, Tew D, Goryanin II.

Biotechnol Bioeng. 2006 Nov 5;95(4):560-73.

PMID:
16921527
20.

Mathematical modeling of mitochondrial adenine nucleotide translocase.

Metelkin E, Goryanin I, Demin O.

Biophys J. 2006 Jan 15;90(2):423-32. Epub 2005 Oct 20.

Supplemental Content

Loading ...
Support Center